Neutra (Neutra) Gross-Profit-to-Asset % : 12.50% (As of Oct. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Neutra Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Neutra's annualized Gross Profit for the quarter that ended in Oct. 2023 was $0.00 Mil. Neutra's average Total Assets over the quarter that ended in Oct. 2023 was $0.03 Mil. Therefore, Neutra's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2023 was 12.50%.

Neutra Gross-Profit-to-Asset % Historical Data

The historical data trend for Neutra's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra Gross-Profit-to-Asset % Chart

Neutra Annual Data

Trend

Jan14

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

3.47

-17.69

19.25

33.98

Neutra Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															36.67	13.87	18.60	17.58	12.50

Competitive Comparison of Neutra's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Neutra's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neutra's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Neutra's Gross-Profit-to-Asset % falls into.

Neutra Gross-Profit-to-Asset % Calculation

Neutra's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jan. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jan. 2023 )	/	( (Total Assets (A: Jan. 2022 )	+	Total Assets (A: Jan. 2023 ))	/ count )
	=	0.035	/	( (0.131	+	0.075)	/ 2 )
	=	0.035	/	0.103
	=	33.98 %

Neutra's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Oct. 2023 )	/	( (Total Assets (Q: Jul. 2023 )	+	Total Assets (Q: Oct. 2023 ))	/ count )
	=	0.004	/	( (0.037	+	0.027)	/ 2 )
	=	0.004	/	0.032
	=	12.50 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Oct. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Neutra Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Neutra's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Neutra (Neutra) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478

Website

https://www.neutrainc.com

Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.

Executives

Sydney Jim

director, officer: CEO & Chairman

8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243